在乳腺癌中,ANXA2通过STAT3信号调节RANKL诱导的骨质细胞分化
Jie Yuan1, Fei Xin2, Ruliang Wang2
1Department of Orthopedics, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, People's Republic of China.
Breast cancer (Dove Medical Press)
|September 24, 2025
概括
这项研究表明,Annexin A2 (ANXA2) 通过通过STAT3-RANKL途径促进骨质细胞分化,驱动乳腺癌骨转移. 针对这一轴可能会提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症转移 癌症转移
背景情况:
- 骨转移显著影响到晚期乳腺癌患者的生存率.
- 骨质细胞在骨解和骨瘤细胞转移中起着至关重要的作用.
- 附录素A2 (ANXA2) 涉及乳腺癌侵袭,但其在骨转移中的作用尚不清楚.
研究的目的:
- 研究ANXA2在乳腺癌骨转移中的作用.
- 阐明ANXA2影响骨质细胞形成和骨转移的分子机制.
主要方法:
- 在乳腺癌队列中分析了ANXA2表达和生存相关性.
- 利用RAW264.7细胞来评估ANXA2对骨质细胞分化的影响.
- 通过RT-PCR,西斑和双 luciferase 记者测定,研究了 STAT3 信号通路和 RANKL 调节.
主要成果:
- 在乳腺癌患者中,ANXA2上调与低生存率相关.
- ANXA2增强了骨质细胞分化,并上调了与骨质细胞相关的基因.
- ANXA2激活了STAT3信号,通过直接与RANKL促进体结合,增加了RANKL的表达.
结论:
- ANXA2 是骨质细胞分化和乳腺癌骨转移的关键调节者.
- ANXA2/STAT3/RANKL轴是驱动骨转移的一个关键途径.
- 针对ANXA2 / STAT3 / RANKL轴为骨转移提供了一个潜在的治疗策略.
相关概念视频
The JAK-STAT Signaling Pathway
12.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.1K
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K


